| |
| |
|
| Insider
Information: |
Boerner Christopher S. |
| Relationship: |
Chief Executive Office... |
| City: |
Bothell |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
173,563 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,111,466 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
173,563 |
|
|
| Total
Value |
$21,111,466 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
1.0
|
| Percentage
Gain/Loss : |
 -9.7%
|
 17.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Seagen Inc |
SGEN |
Executive Vice Preside... |
2014-08-26 |
72,358 |
2011-08-19 |
0 |
Premium* |
|
|
Bristol-Myers Squibb Co |
BMY |
Chief Executive Office... |
2024-03-10 |
101,205 |
2019-02-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2011-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
819 |
1,801 |
0 |
- |
|
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2011-08-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
6,301 |
0 |
- |
|
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2012-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
21,348 |
0 |
- |
|
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2012-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
33,753 |
0 |
- |
|
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2013-03-15 |
4 |
S |
$33.61 |
$285,663 |
D/D |
(8,500) |
33,753 |
0 |
- |
|
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2013-03-15 |
4 |
OE |
$15.10 |
$128,350 |
D/D |
8,500 |
42,253 |
0 |
- |
|
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2013-08-19 |
4 |
AS |
$40.91 |
$9,246 |
D/D |
(226) |
33,527 |
0 |
- |
|
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2013-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
47,527 |
0 |
- |
|
| SGEN |
Seagen Inc |
SVP, Commercial |
• – – |
2014-02-21 |
4 |
S |
$54.98 |
$79,825 |
D/D |
(1,452) |
46,075 |
0 |
- |
|
| SGEN |
Seagen Inc |
EVP, Commercial |
• – – |
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
57,514 |
0 |
- |
|
| SGEN |
Seagen Inc |
Executive Vice President, Comm |
• – – |
2014-08-24 |
4 |
AS |
$43.55 |
$54,349 |
D/D |
(1,248) |
56,358 |
0 |
- |
|
| SGEN |
Seagen Inc |
Executive Vice President, Comm |
• – – |
2014-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
16,000 |
72,358 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2019-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,465 |
4,465 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2019-02-02 |
4 |
D |
$49.89 |
$79,375 |
D/D |
(1,591) |
2,874 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,707 |
14,501 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,247) |
5,933 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2019-03-10 |
4 |
D |
$51.39 |
$408,448 |
D/D |
(7,948) |
9,386 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,497 |
27,190 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
21,426 |
26,091 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(109) |
12,811 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2020-03-10 |
4 |
D |
$57.43 |
$701,756 |
D/D |
(12,167) |
21,033 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2020-12-02 |
4 |
D |
$62.18 |
$80,772 |
D/D |
(1,299) |
22,371 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2020-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,637 |
23,670 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2021-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(154) |
25,022 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, Chief Commercial Officer |
• – – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,215 |
41,325 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
